Blood test for advanced biliary tract cancer
Part of Cancer, Digestive system clinical trials.
This study uses a simple blood test (ctDNA) to learn more about the genetic makeup of advanced biliary tract cancers. It may help researchers understand how these cancers respond to treatment, and it doesn't involve any extra drugs or procedures—just blood draws.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic biliary tract cancer (bile duct or gallbladder cancer that has spread).
- You are either about to start your first treatment, or you've had treatment before and are about to start a new one.
- You are 19 years old or older.
- You are willing to give blood samples for a special ctDNA test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a blood test called ctDNA to look at the genetic makeup of your cancer. It aims to learn more about bile duct cancer and may help guide your treatment choices.
This trial uses a blood test (ctDNA) to look for genetic material from tumors in patients with gastrointestinal cancers. It may help doctors understand and track your cancer better.
This trial studies a new blood test that looks for bits of tumor DNA (ct-mtDNA) to see if it can detect if biliary tract cancer has come back earlier than standard scans. The test might help doctors monitor for recurrence more closely.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
Hear when a new Biliary Tract Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.